Irvine, Calif. - Allergan Inc., contrary to popular belief, isn't fighting the U.S. Food and Drug Administration's allegations that statements in Botox Cosmetic advertisements are misleading, thus violating of the Food, Drug, and Cosmetic Act.
Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
POLL: What Strategies Have You Found Most Effective in Managing Alopecia?
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging
Pointers With Portela: What to Know About Ozempic
2 Clarke Drive Cranbury, NJ 08512